We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Research Shows Laparoscopic and Open Gastrectomy Outcomes Are Similar

By HospiMedica International staff writers
Posted on 25 Feb 2019
Patients with gastric cancer who undergo laparoscopic distal gastrectomy have long-term survival rates comparable to those who undergo open gastrectomy, according to a new study.

Researchers at Seoul National University Bundang Hospital (Seongnam, South Korea), Yonsei University College of Medicine (Seoul, South Korea), and 11 other institutions in Korea conducted a study involving 1,416 patients (mean age, 57.3 years; 66.4% male) with stage I gastric cancer to examine if the surgical approach affected long-term survival. More...
Participants were randomly assigned to laparoscopic distal gastrectomy (705 patients) or open distal gastrectomy (711 patients). The main outcome was the difference in five year overall survival between the two groups.

The resulted showed five year overall survival rates were 94.2% in the laparoscopic group and 93.3% in the open surgery group; cancer-specific survival was also similar, at 97.1% and 97.2%, respectively. An intention-to-treat analysis confirmed the non-inferiority of the laparoscopic approach to the open approach. During the course of the study, 85 patients received a surgical approach opposite the one to which they were randomized, but per-protocol analysis results remained consistent with those using the intention-to-treat analysis. The study was published on February 7, 2019, in JAMA Oncology.

“Laparoscopic distal gastrectomy is gaining popularity over open distal gastrectomy for gastric cancer because of better early postoperative outcomes. However, to our knowledge, no studies have proved if laparoscopic distal gastrectomy is oncologically equivalent to open distal gastrectomy,” concluded lead author Woo Jin Hyung, MD, of Yonsei University College of Medicine, and colleagues. “The trial revealed similar overall and cancer-specific survival rates between patients. Laparoscopic distal gastrectomy is an oncologically safe alternative to open surgery for stage I gastric cancer.”

Five layers of tissue make up the stomach wall – the mucosa, submucosa, muscle, connective tissue (subserosa), and serosa. Gastric cancer begins in the mucosa and spreads through the outer layers as it grows. Treatment options for stage I gastric cancer (as examined in the study) includes total or subtotal gastrectomy, followed by optional chemotherapy. Other modalities include radiation therapy, targeted therapy, and immunotherapy.

Related Links:
Seoul National University Bundang Hospital
Yonsei University College of Medicine


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.